Cargando…

Implementing the New Guidelines for Hypertension

Detalles Bibliográficos
Autor principal:	Carter, Barry L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2004
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437527/ https://www.ncbi.nlm.nih.gov/pubmed/15369421 http://dx.doi.org/10.18553/jmcp.2004.10.S5-A.S18

Ejemplares similares

Opioid Dependence Treatment and Guidelines
por: Nicholls, Lance, et al.
Publicado: (2010)

Influencing Patient Adherence to Treatment Guidelines
por: Butterworth, Susan W.
Publicado: (2008)

Current Perspectives on Hypertension and Metabolic Syndrome
por: Bakris, George L.
Publicado: (2007)

Guidelines and Performance Measures for the Prevention and Treatment of Venous Thromboembolism
por: Fanikos, John
Publicado: (2008)

Guidelines and Performance Measures for the Management of Acute Coronary Syndrome
por: Sobieszczyk, Piotr
Publicado: (2008)

Case Study: The Link Between Hypertension and Diabetes
por: Bakris, George L., et al.
Publicado: (2007)

Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012)

Epidemiology and Unmet Needs in Hypertension
por: Flack, John M.
Publicado: (2007)

Continuing Education
por: Carter, Barry L., et al.
Publicado: (2004)

Implement Community Based Standards of Care
por: Urick, Paul N.
Publicado: (2005)

Case Study: Pearls in Hypertension Pharmacotherapy
por: Cohen, Jerome D.
Publicado: (2007)

Identifying Indicators of Outcomes and Implementing Treatment Pathways
por: Huff, Carol Ann, et al.
Publicado: (2012)

Overview of Physiology, Vascular Biology, and Mechanisms of Hypertension
por: Cohen, Jerome D.
Publicado: (2007)

Applying Quality Measures and Guidelines in the Management of Acute Coronary Syndrome and Venous Thromboembolism Introduction
por: Gulseth, Michael P.
Publicado: (2008)

Challenges of Program Implementation in a Managed Care Environment
por: Christiansen, Blake
Publicado: (2006)

Disease Progression and the Application of Evidence-Based Treatment Guidelines Diagnose It Early: A Case for Screening and Appropriate Management
por: Manley, Harold J.
Publicado: (2007)

New Treatment Options in COPD
por: Hillman, Daniel E.
Publicado: (2005)

New Strategies in Controlling Drug Resistance
por: Frame, David
Publicado: (2007)

Can CER Be an Effective Tool for Change in the Development and Assessment of New Drugs and Technologies?
por: Brixner, Diana I., et al.
Publicado: (2012)

Something Old, Something New, Something Borrowed"¦Comparative Effectiveness Research: A Policy Perspective
por: Subedi, Prasun, et al.
Publicado: (2011)

Merging P4P and Disease Management: How Do You Know Which One Is Working?
por: Smith, Allen L.
Publicado: (2007)

The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
por: Talbert, Robert L.
Publicado: (2008)

Pharmacological Augmentation of Endothelium-Derived Nitric Oxide Synthesis
por: Bakris, George L.
Publicado: (2007)

Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007)

Strategies for Optimizing Treatment Outcomes
por: Jones Freeman, Elyce L.
Publicado: (2003)

Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program
por: Chao, Schumarry H., et al.
Publicado: (2007)

Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies
por: Owens, Gary M., et al.
Publicado: (2013)

Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

Continuing Education
por: Lipsy, Robert J., et al.
Publicado: (2004)

Pharmacoeconomic Challenges in the Management of Diabetic Nephropathy
por: Rodby, Roger A.
Publicado: (2004)

The Importance and Impact of Evidence Based medicine
por: Lewis, Sonya J., et al.
Publicado: (2004)

Emerging Trends for Prevention and Treatment of Diabetic Nephropathy
por: Hunsicker, Lawrence G.
Publicado: (2004)

Preview Overview
por: Lipsy, Robert J.
Publicado: (2004)

Introduction
por: Rumsfeld, John S.
Publicado: (2006)

Potential Advantages of Interprofessional Care in Rheumatoid Arthritis
por: Marion, Carrie Engen, et al.
Publicado: (2011)

Practice Strategies to Improve Compliance and Patient Self-Management
por: Ruetsch, Charles
Publicado: (2010)

Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
por: Menzin, Joseph, et al.
Publicado: (2013)

COPD Clinical Significance of Early Diagnosis
por: Leff, Richard D.
Publicado: (2005)

Pharmacy Management Strategies for Improving Drug Adherence
por: Fleming, William K.
Publicado: (2008)

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy
por: Watson, Karol E.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_tt5mpcdm9sp05t04hl3rmmqhjf